✦ LIBER ✦

Plasminogen activators in oesophageal carcinoma

✍ Scribed by Mr D. F. Hewin; P. B. Savage; D. Alderson; M. N. Vipond

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 423 KB
Volume: 83
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800830838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EXPRESSION OF PLASMINOGEN ACTIVATORS IN

EXPRESSION OF PLASMINOGEN ACTIVATORS IN BASAL CELL CARCINOMA

✍ SPIERS, ELIZABETH M.; LAZARUS, GERALD S.; LYONS-GIORDANO, BERNADETTE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

The plasminogen activators, tissue type and urokinase type (tPA and uPA, respectively), have been identified in various malignancies and have been implicated in both local growth and metastatic spread. To characterize plasminogen activator expression more fully in human basal cell carcinoma, the loc

Plasminogen activator inhibitor 1 in hum

Plasminogen activator inhibitor 1 in human carcinoma tissues

✍ Nobuya Tanaka; Hideharu Fukao; Shigeru Ueshima; Kiyotaka Okada; Masayuki Yasutom 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 577 KB

## Abstract The content of PAI‐1 was measured in carcinoma tissues from the stomach and colorectum divided macroscopically into 3 portions: the central part of the carcinoma, the marginal part of the carcinoma containing some normal mucosa, and the normal mucosa. Among these tissues, the highest le

Expression of plasminogen activators and

Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma

✍ Carsten Häckel; Bogdan Czerniak; Alberto G. Ayala; Kathrin Radig; Albert Roessne 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

## Background: The plasminogen activator system plays an important role in different malignant tumors. these enzymes participate in the destruction of intercellular matrices and basement membranes and/or can modulate the growth potency of tumor cells and may even promote metastases. in this study,

Plasminogen activators and their inhibit

Plasminogen activators and their inhibitors in leukemic cell homogenates

✍ Hideo Wada; Yasurou Kumeda; Zin Ogasawara; Michiaki Ohiwa; Toshihiro Kaneko; Shi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

Plasminogen activator (PA) and PA inhibitor (PAI) were measured in homogenates of leukemia cells. Both PA and PA1 levels were higher in non-lymphobiastic leukemia than in lymphobiastic leukemia. The levels were below the sensitivity of determination in chronic myeiocytic leukemia (CML) but showed si

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA

✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an

Primary oesophageal carcinoma in teens

✍ Dr. Arvind Kumar; Nutan K. Shukla; Mahesh C. Mishra; Uday P. Shahi; Brij M. L. K 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Seven teenaged patients with primary oesophageal carcinoma, treated at our hospital in the last 6 years are presented and their management discussed. Five patients had localised disease. Three of them underwent total oesophagectomy, one was given radical radiotherapy, and one was lost to follow-up.